As has happened with other health IT innovations like CRISPR, mRNA-based organizations could share their core technology with each other and develop new products around their common base. This could lead to new ecosystems of mRNA platforms that innovate to create new solutions in the pharmaceutical industry.
Big companies may also move to share their technology with one another, opening up the potential for accelerated innovation. Pharmaceutical giants like Moderna and BioNTech have already moved to open up their mRNA technologies to other large pharmaceutical companies in an attempt to build an industry platform.
If mRNA technologies prove to be broadly applicable across the pharmaceutical industry, they may become to pharmaceuticals what Apple’s iOS is to the digital sector, a tightly controlled but technological core to the industry, argue the international team of researchers who authored the piece.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
